Hemofiltration in sepsis and systemic inflammatory response syndrome: The role of dosing and timing

Bouman, Catherine S.C.; Oudemans-van Straaten, Heleen M.; Schultz, Marcus J.; Vroom, Margreeth B.

doi:10.1016/j.jcrc.2006.05.002

« Previous Next »Journal of Critical Care
Volume 22, Issue 1 , Pages 1-12, March 2007

Hemofiltration in sepsis and systemic inflammatory response syndrome: The role of dosing and timing☆

Catherine S.C. Bouman, MD
- Department of Intensive Care, Academic Medical Center, University of Amsterdam, PO 22660, 1100 DD Amsterdam, The Netherlands
- Corresponding author. Tel.: +31 20 5662509.
Heleen M. Oudemans-van Straaten, MD, PhD
- Laboratory of Experimental Intensive Care and Anesthesiology, Academic Medical Center, University of Amsterdam, 1100 DD Amsterdam, The Netherlands
Marcus J. Schultz, MD, PhD
- Department of Intensive Care, Academic Medical Center, University of Amsterdam, PO 22660, 1100 DD Amsterdam, The Netherlands
- Department of Intensive Care, Onze Lieve Vrouwe Gasthuis, PO 95500, 1090 HM Amsterdam, The Netherlands
Margreeth B. Vroom, MD, PhD
- Department of Intensive Care, Academic Medical Center, University of Amsterdam, PO 22660, 1100 DD Amsterdam, The Netherlands

published online 03 February 2007.

To access this article, please choose from the options below

☆ CSCB performed the search, analyzed the data, and drafted the manuscript. HMO-vS contributed to the search. HMO-vS, MJS, and MBV critically reviewed the manuscript.

PII: S0883-9441(06)00083-9

doi:10.1016/j.jcrc.2006.05.002

« Previous Next »Journal of Critical Care
Volume 22, Issue 1 , Pages 1-12, March 2007

Access this article on SciVerse ScienceDirect